Lester D, Burton C, Gardner A, Innamarato P, Kodumudi K, Liu Q
Nat Cancer. 2023; 4(2):222-239.
PMID: 36690875
PMC: 9970875.
DOI: 10.1038/s43018-022-00506-7.
Maszczak-Seneczko D, Wiktor M, Skurska E, Wiertelak W, Olczak M
Int J Mol Sci. 2022; 23(15).
PMID: 35955785
PMC: 9368800.
DOI: 10.3390/ijms23158648.
Boyer S, Johnsen C, Morava E
Trends Mol Med. 2022; 28(6):463-481.
PMID: 35562242
PMC: 9375550.
DOI: 10.1016/j.molmed.2022.04.003.
Park J, Reunert J, He M, Mealer R, Noel M, Wada Y
Mol Genet Metab Rep. 2020; 25:100680.
PMID: 33312876
PMC: 7719959.
DOI: 10.1016/j.ymgmr.2020.100680.
Das J, Sharma A, Jindal A, Aggarwal V, Rawat A
Genes Dis. 2020; 7(1):107-114.
PMID: 32181281
PMC: 7063431.
DOI: 10.1016/j.gendis.2019.07.012.
Congenital disorders of glycosylation.
Chang I, He M, Lam C
Ann Transl Med. 2019; 6(24):477.
PMID: 30740408
PMC: 6331365.
DOI: 10.21037/atm.2018.10.45.
CDG Therapies: From Bench to Bedside.
Brasil S, Pascoal C, Francisco R, Marques-da-Silva D, Andreotti G, Videira P
Int J Mol Sci. 2018; 19(5).
PMID: 29702557
PMC: 5983582.
DOI: 10.3390/ijms19051304.
Neutrophil Evolution and Their Diseases in Humans.
Leiding J
Front Immunol. 2017; 8:1009.
PMID: 28894446
PMC: 5581313.
DOI: 10.3389/fimmu.2017.01009.
Immunological aspects of congenital disorders of glycosylation (CDG): a review.
Monticelli M, Ferro T, Jaeken J, Dos Reis Ferreira V, Videira P
J Inherit Metab Dis. 2016; 39(6):765-780.
PMID: 27393411
DOI: 10.1007/s10545-016-9954-9.
Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology.
Lyons J, Milner J, Rosenzweig S
Front Pediatr. 2015; 3:54.
PMID: 26125015
PMC: 4463932.
DOI: 10.3389/fped.2015.00054.
A novel mutation in leukocyte adhesion deficiency type II/CDGIIc.
Cagdas D, Yilmaz M, Kandemir N, Tezcan I, Etzioni A, Sanal O
J Clin Immunol. 2014; 34(8):1009-14.
PMID: 25239688
DOI: 10.1007/s10875-014-0091-7.
Inborn errors of metabolism underlying primary immunodeficiencies.
Parvaneh N, Quartier P, Rostami P, Casanova J, de Lonlay P
J Clin Immunol. 2014; 34(7):753-71.
PMID: 25081841
DOI: 10.1007/s10875-014-0076-6.
Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect.
Dauber A, Ercan A, Lee J, James P, Jacobs P, Ashline D
Hum Mol Genet. 2014; 23(11):2880-7.
PMID: 24403049
PMC: 4014190.
DOI: 10.1093/hmg/ddu001.
Therapies and therapeutic approaches in Congenital Disorders of Glycosylation.
Thiel C, Korner C
Glycoconj J. 2012; 30(1):77-84.
PMID: 22983739
DOI: 10.1007/s10719-012-9447-5.
Metabolic manipulation of glycosylation disorders in humans and animal models.
Freeze H, Sharma V
Semin Cell Dev Biol. 2010; 21(6):655-62.
PMID: 20363348
PMC: 2917643.
DOI: 10.1016/j.semcdb.2010.03.011.
Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature.
Gazit Y, Mory A, Etzioni A, Frydman M, Scheuerman O, Gershoni-Baruch R
J Clin Immunol. 2010; 30(2):308-13.
PMID: 20099014
DOI: 10.1007/s10875-009-9354-0.
Defects in the leukocyte adhesion cascade.
Etzioni A
Clin Rev Allergy Immunol. 2009; 38(1):54-60.
PMID: 19437145
DOI: 10.1007/s12016-009-8132-3.
The congenital disorders of glycosylation: a multifaceted group of syndromes.
A Eklund E, Freeze H
NeuroRx. 2006; 3(2):254-63.
PMID: 16554263
PMC: 3593443.
DOI: 10.1016/j.nurx.2006.01.012.
Golgi nucleotide sugar transport and leukocyte adhesion deficiency II.
Hirschberg C
J Clin Invest. 2001; 108(1):3-6.
PMID: 11435449
PMC: 209350.
DOI: 10.1172/JCI13480.